Design and Materials
Constructed from Croslite™ material and durable rubber, the upper is lightweight, water-resistant, and easy to maintain. The synthetic build requires minimal care—just rinse or wipe clean. Its dragon fruit pink finish adds a vibrant touch, while the rounded toe with slight reinforcement provides structure and balances the overall shape.
This clog features an open design without traditional closures. An adjustable heel strap allows for two modes of wear: slip-on or heel-secured. The design supports versatility, whether used as everyday sliders or for longer walks in the city.
Comfort Technology
Equipped with Crocs Comfort™, the pair provides lasting cushioning through proprietary Croslite™ foam. This material absorbs shock effectively and retains its form over time, contributing to consistent comfort with extended use. A grooved insole helps stabilize the foot during movement.
The 6 cm platform offers added height without compromising balance. Weight is evenly distributed across the footbed, supporting ergonomic alignment during wear.
Functional Features
- Platform Height: 6 cm platform for increased elevation with balanced support
- Water-Resistant: Synthetic materials resist moisture and dry quickly
- Two-Way Wear: Adjustable heel strap enables both slip-on and secured fit options
- Rounded Toe with Structure: Slightly reinforced front enhances durability and shape retention
- No Closure System: Slip-on format allows quick, easy wear
Style and Versatility
The Crocs Classic Bae Clog Dragon Fruit features a vivid fuchsia tone that aligns with current seasonal palettes while maintaining the brand’s playful aesthetic. Sculpted lines and an elevated sole give it a more fashion-forward appearance than standard clogs. It pairs well with wide-leg trousers, shorts, or casual dresses.
The model serves those seeking women's platform Crocs that combine functional benefits such as water resistance and low maintenance with standout color options. It suits warm-weather use and casual daily styling where comfort remains a priority.
